What is Humanity?
Headquartered in London, United Kingdom, Humanity operates at the intersection of mobile technology and preventative medicine. The company provides a sophisticated mobile application designed to help users monitor and improve their biological age through personalized health advice. By analyzing diverse data points, the platform empowers individuals to make informed lifestyle choices that enhance immune function and promote long-term vitality. As the company transitions from its initial development phase into a more mature enterprise-level entity, it continues to refine its proprietary algorithms to deliver high-precision health guidance to a global user base.
How much funding has Humanity raised?
Humanity has raised a total of $5M across 2 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M with participation from Esther Dyson and One Way Ventures
Angel/Seed (2021): $2.5M led by Taavet Hinrikus, Seedcamp, Michael Acton-Smith, Alexander Ljung, Robin Thurston, Alex Tew, Breega, One Way Ventures, 7Percent Ventures, and Esther Dyson
Key Investors in Humanity
Seedcamp
Seedcamp is a venture capital firm that supports early-stage startups by providing investment, mentorship, and access to a global network, focusing on ambitious founders across various sectors.
Breega
Breega is a venture capital firm that specializes in backing exceptional founders from pre-Seed to Series A+ across Digital, Climate, and Deep Tech sectors, providing both financial support and tactical expertise.
Esther Dyson
Esther Dyson is an author, investor, and philanthropist focused on the intersection of technology, health, and emerging markets, known for her strategic investments in healthcare and artificial intelligence.
What's next for Humanity?
With the infusion of $2.5M, Humanity is poised to accelerate its product development roadmap and expand its market reach. The strategic focus will likely shift toward enhancing the platform's predictive capabilities and deepening its integration with wearable health devices. As the company navigates this growth phase, the support from its diverse investor base—ranging from specialized venture capital firms to prominent angel investors—will be instrumental in scaling operations and establishing a dominant presence in the competitive longevity-tech landscape. Future milestones will likely involve scaling user acquisition and potentially exploring enterprise partnerships to integrate their health-optimization tools into broader wellness ecosystems.
See full Humanity company page
